genedrive plc launches new interactive investor hub
genedrive plc (LON: GDR), the point of care pharmacogenetic testing company, is pleased to announce the launch of our interactive investor hub. For both existing and prospective shareholders, over time the new investor hub will bring all genedrive content into a single integrated platform to better inform and engage with investors and stakeholders.
The investor hub provides an interactive online experience allowing genedrive stakeholders to comment on and ask the genedrive team questions via a portal which will be monitored and responded to as timely as possible.
How to sign up for the genedrive investor hub:
1. Visit investors.genedrive.com
2. Follow the prompts to sign up for an investor hub account
3. Complete your account profile
Dr Gino Miele, CEO of genedrive plc, said: “Open and transparent communication with our shareholders is essential, particularly in a fast-moving environment like ours. Whilst RNS remains the first source of regulated news on genedrive, the investor hub gives us a direct channel to share accurate information and meaningful updates straight from the company ensuring investors hear from us directly. The hub enables shareholders to submit questions, receive updates, and engage directly with the Company. We encourage all investors to register and use the hub as their central source for trusted updates, insights, and dialogue with our team.”
Engage with the genedrive management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor hub here: https://investors.genedrive.com/link/PZ3d7y
For further information, please contact:
|
Genedrive plc Dr Gino Miele (CEO) Russ Shaw (CFO) |
https://investors.genedrive.com/s/e0025c +44 (0) 161 989 0245 |
